Please login to the form below

Not currently logged in
Email:
Password:

Cuttsy and Cuttsy appoints Jill Bradshaw

She joins as an account director from VCCP Health
Jill Bradshaw

Cambridgeshire, UK-based comms agency Cuttsy and Cuttsy has appointed Jill Bradshaw as an account director.

Bradshaw joins from VCCP Health, where she worked in the same role on international campaigns with the likes of Lundbeck and Roche.

She has also previously worked on developing marketing campaigns for MSD and Pfizer, as well as over the counter brands such as Sudocrem.

The firm's co-director Mathew Cutts said: “We are always looking for people that can bring something to the business. Jill has expertise and experience that will help our clients as well as add to the business as a whole.”

Brandshaw's appointment follows the firm's promotion last year of Sarah Ings, who moves up to the role of planner.

She joined Cuttsy and Cuttsy in 2013 as an account director and has over 12 years of experience in healthcare communications, having worked for the likes of MJL Advertising, Grey Healthcare Group and Photosound.

Commenting on her promotion, Ings said: “Strategic account planning has always been the part of my role that I have enjoyed the most. When the agency started looking for a planner I put myself forward and after a tougher than expected interview process was given the role.

“I am looking forward to concentrating on this side of things, proving myself and working on some great campaigns that we have bubbling in the pipeline.”

14th January 2015

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
GK Strategy

GK is award-winning independent communications agency specialising in delivering impactful strategies for clients across the healthcare market....

Latest intelligence

Brain power: fresh approaches to Alzheimer’s drug discovery
New alliances are learning from past mistakes and breaking down research barriers...
Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...
London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...

Infographics